The Patent Finder

Terms ending in 2033

Chemocentryx, Inc.

Every in-force patent on Chemocentryx, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,835,419Substituted Anilines as CCR(4) Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,133,124Crystalline Form of the Sodium Salt of 4-TERT-BUTYL-N-[4-Chloro-2-(1-OXY-PYRIDINE-4-Carbonyl)-PHENYL]-BENZENESULFONAMIDE
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 8,916,601Aza-Aryl 1H-PYRAZOL-1-YL Benzene Sulfonamides
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 10,137,120Aza-Aryl 1H-PYRAZOL-1-YL Benzene Sulfonamides
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 10,596,163Aza-Aryl 1H-PYRAZOL-1-YL Benzene Sulfonamides
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 12,611,404Aza-Aryl 1H-PYRAZOL-1-YL Benzene Sulfonamides
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,169,261CXCR7 Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,783,544CXCR7 Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 10,287,292CXCR7 Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,059,825CXCR7 Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
7 more term ends in 2033 · Pro
10 of 17 patents shown. Soonest term end first, then patent number.
Pro members see all 17.
Upgrade to Pro
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited